Multiple Sclerosis New Study Data to Peginterferon beta-1a

被引：0
|
作者：
不详
机构：
来源：
AKTUELLE NEUROLOGIE | 2015年 / 42卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [1] Peginterferon Beta-1a (Plegridy) for Multiple Sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1468): : 1 - 3
  • [2] Peginterferon beta-1a for the treatment of relapsing multiple sclerosis: A case series
    Hendin, Barry A.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 26 : 33 - 36
  • [3] Peginterferon beta-1a - a new form of interferon beta-1a
    Maciejek, Zdzislaw
    Niezgodzinska-Maciejek, Anna
    AKTUALNOSCI NEUROLOGICZNE, 2015, 15 (03): : 135 - 138
  • [4] Peginterferon beta-1a concentrations in breast milk of lactating multiple sclerosis patients
    Houtchens, Maria
    Mahlanza, Tatenda
    Ciplea, Andrea, I
    Manieri, Maria Claudia
    Ramia, Nancy F.
    Zhao, Yuan
    England, Sarah
    Avila, Robin
    Altincatal, Arman
    Vignos, Megan
    Hellwig, Kerstin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
  • [5] Peginterferon beta-1a reduces the psychological impact of multiple sclerosis relapses: results from the ADVANCE study
    Kinter, E.
    Guo, S.
    Altincatal, A.
    Proskorovsky, I.
    Phillips, G.
    Sperling, B.
    JOURNAL OF NEUROLOGY, 2014, 261 : S441 - S441
  • [6] Clinical efficacy and safety of peginterferon beta-1a in relapsing multiple sclerosis: data from the pivotal phase 3 ADVANCE study
    Kieseier, B.
    Arnold, D. L.
    Balcer, L.
    Boyko, A.
    Pelletier, J.
    Deykin, A.
    Hung, S.
    Seddighzadeh, A.
    Liu, S.
    Zhu, Y.
    Sperling, B.
    Calabresi, P.
    JOURNAL OF NEUROLOGY, 2013, 260 : S12 - S13
  • [7] Peginterferon beta-1a reduces the psychological impact of multiple sclerosis relapses: results from the ADVANCE study
    Kinter, E.
    Guo, S.
    Altincatal, A.
    Proskorovsky, I.
    Phillips, G.
    Sperling, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 681 - 681
  • [8] Clinical Efficacy and Safety of Peginterferon beta-1a in Relapsing Multiple Sclerosis: Data from the Pivotal Phase 3 ADVANCE Study
    Calabresi, Peter
    Kieseier, Bernd
    Arnold, Douglas
    Balcer, Laura
    Boyko, Alexey
    Pelletier, Jean
    Liu, Shifang
    Zhu, Ying
    Seddighzadeh, Ali
    Sperling, Bjorn
    Hung, Serena
    Deykin, Aaron
    NEUROLOGY, 2013, 80
  • [9] Effects of switching from placebo to peginterferon beta-1A in the advance study in patients with relapsing multiple sclerosis
    Shang, S.
    Evilevitch, V.
    You, X.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E303 - E303
  • [10] BUDGET IMPACT ANALYSIS FOR PEGINTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE SCLEROSIS IN ITALY
    Iannazzo, S.
    Santoni, L.
    Saleri, C.
    Puma, E.
    Vestri, G.
    Giuliani, L.
    Centonze, D.
    Canonico, P. L.
    VALUE IN HEALTH, 2015, 18 (07) : A752 - A752
12345